Evidence brief · printable

Amyotrophic Lateral Sclerosis evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Amyotrophic Lateral Sclerosis

Print or save as PDF Fits on one A4 or Letter page.

Amyotrophic Lateral Sclerosis: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/amyotrophic-lateral-sclerosis.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Riluzole 3 trials
  • Mexiletine 2 trials
  • Ranolazine 2 trials
  • 100% of individual calory requirement 1 trial
  • 120% of individual calory requirement 1 trial
  • 50 mg Usnoflast 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Transcranial brain stimulation (tDCS, TMS) 10 trials · 4 completed · 2 with results
  • Breathing and respiratory muscle training 10 trials · 5 completed · 1 with results
  • Creatine 5 trials · 4 completed · 1 with results
  • Psychotherapy, counselling and peer support 4 trials · 3 completed · 1 with results
  • Nutrition counselling and food-based products 3 trials · 2 completed · 1 with results
  • Intermittent hypoxia and hyperoxia 1 trials · 1 completed · 1 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Creatine

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS NCT07322003
  • A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With… NCT07855211
  • Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS NCT07287397
  • Assessing Perceptual Effects of Interactive Tasks NCT06828523
  • Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People… NCT07454733
  • Evaluating Verbal Communication in Structured Interactions: Theoretical and… NCT06266403

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 10 trials of breathing and respiratory training found, none measured symptom severity and disease activity 22 trials of other approaches did
  • Among 21 trials of supplements and nutraceuticals found, none measured physical function and exercise capacity 14 trials of other approaches did
  • Among 8 trials of diet, fasting and nutrition found, none measured physical function and exercise capacity 14 trials of other approaches did
  • Exercise and physical activity: physical function and exercise capacity 6 trials, no results posted yet
  • Exercise and physical activity: breathing and lung function 4 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (94 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.